Recognising the importance of plasma and with over 60 years of experience in the industry, BPL supplies high-quality plasma-derived medicines to meet the needs of clinicians, patients and customers globally.
Headquartered in Elstree, in the UK, and with plasma collection centres across the US, BPL is dedicated to producing a range of medicines for the treatment of immune deficiencies, bleeding disorders and infectious diseases as well for critical care.
BPL’s plasma-derived medicines are commercially available in more than 50 countries worldwide through its network of local affiliates and distribution partners.
Our Commitment
Our purpose is to enhance the lives of patients every day and support healthcare professionals by providing high-quality plasma-derived therapies worldwide.
What We Do
We are a trusted leader, an innovator and partner of choice in the processing of human plasma – collecting, developing, producing and commercialising a variety of plasma therapies worldwide.
BPL consists of two operating divisions, BPL Therapeutics (consisting of BPL Therapeutics in the UK and BPL Therapeutics US), and BPL Plasma.
|
Address: Dagger Ln, Elstree, Radlett, Borehamwood WD6 3BX United Kingdom |
© Copyright Mark Allen Group | Registered in England No. 0677986
